Vanguard Personalized Indexing Management, LLC Lyell Immunopharma, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $4.59 Billion
- Q1 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 16,379 shares of LYEL stock, worth $24,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,379
Previous 15,917
2.9%
Holding current value
$24,732
Previous $30,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LYEL
# of Institutions
128Shares Held
144MCall Options Held
0Put Options Held
5.9K-
Mwg Management Ltd. Washington, DC20.2MShares$30.4 Million33.29% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$22.8 Million19.02% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$22.8 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$21 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$20.2 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $374M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...